BioSpace News Archive

Check-Cap Ltd., a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer, announced financial results for the first quarter ended March 31, 2022.

Remix Therapeutics announced that Peter Smith, Ph.D., Co-Founder and Chief Executive Officer of Remix, will present a corporate overview at the Jefferies Healthcare Conference on Wednesday, June 8, 2022, at 4:30 p.m. ET in New York.

Microbion Corporation announced that the company will present a poster highlighting the in vitro activity of pravibismane against M. avium and M. abscessus non-tuberculous mycobacteria at the Colorado Mycobacteria Conference 2022: Focus on NTM conference taking place from May 31 to June 3, 2022, at Colorado State University.

Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, announced that management will participate in two upcoming investor conferences in June.

Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, announced that Michael Gilman, Ph.D., Chief Executive Officer, will present a corporate overview at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 3:30 p.m. ET in New York.

AnHeart Therapeutics (“AnHeart”), a clinical-stage global biopharmaceutical company committed to developing novel precision oncology therapeutics, announced today it will present at the Jefferies 2022 Global Healthcare Conference in New York on Friday, June 10 at 9:00 AM.

Amneal Launches LYVISPAH ® (baclofen) for Spasticity Related to Multiple Sclerosis and Other Spinal Cord Disorders.

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the following upcoming investor conferences: 2022 Jefferies Healthcare Conference on Wednesday, June 8th at 3:00 p.m. ET 43rd Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 14th at 12:20 p.m. ET.

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the upcoming investor conferences.

Oncology Development Veteran to Lead the Advancement of OncoNano’s Portfolio.